Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Mitchell (Calgary, Canada), M. Saleem (Toronto, Canada), A. Li (Toronto, Canada), M. Ruff (Calgary, Canada), K. Lanctot (Toronto, Canada), B. Paes (Hamilton, Canada). An assessment of the use of palivizumab over 12 years from a Canadian Registry (CARESS).. 1006

Member's Comments

No comment yet.

Related content which might interest you: RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011) Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012 Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011) Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011) Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 CARESS: The Canadian registry of palivizumab (2005-2010) Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011 Contamination during 4-5 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST) Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Assessment of factors influencing adherence to asthma treatment among 12-17 year olds: A multi-national survey in France, Germany, Spain and United Kingdom Source: International Congress 2016 – Asthma management in primary care Year: 2016 The influence of age, region and season on asthma admissions in NHS England for the years 2000-2014 Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 The Nippon COPD Epidemiology (NICE) II Study: follow-up after 3.5 years Source: Eur Respir J 2005; 26: Suppl. 49, 593s Year: 2005 Changes in the treatment of asthma in Spain in the last twenty years. A population based study (ECRHS) Source: International Congress 2014 – Epidemiology of asthma Year: 2014 Asthma medication from 2 to 13 years in a Swedish birth cohort Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL) Source: Virtual Congress 2020 – Hot topics in paediatric asthma Year: 2020 RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012) Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Evaluating the use of the Australian and New Zealand COPD guidelines (The COPD-X Plan) in clinical practice: a user survey Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice Year: 2020 Epidemiological survey of asthma in children aged 1-14 years in the Vinnitsa Region, Ukraine between 2011 and 2012 Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Pulmonary rehabilitation (PR) in adults with COPD and Heart Failure (HF); data from the UK 2015 National COPD:PR Audit Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 The Northjutland COPD follow-up prevention study (NCPS) Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Update on asthma control in five European countries: results of a 2008 survey Source: Eur Respir Rev 2009; 19: 150-157 Year: 2010 GOLD ABCD assessment tool: Comparison of 2013 and 2017 classifications in the UK Clinical Practice Research Datalink (CPRD) Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018